Our 2nd Continuous Intelligence Unit report is now out. Expanding trials across the continent = earlier access + stronger science in diverse populations. Regulators are harmonising to make this easier. Read the full report: accesstomedicinefoundation.org/access-insig...

How can #investors help expand #Access2Meds in #LMICs? In episode 3️⃣ of The Health Equity podcast, @jayiyer.bsky.social talks with PGGM’s Rogier Snijdewind about responsible investment as a catalyst for change in #GlobalHealth. Catch this & other episodes➡️ bit.ly/47DVz7s #GlobalHealth #podcast

I am grateful to this exceptional group of global health leaders for lending their expertise to shape the next Access to Medicine Index #ATMI26. Their guidance helps ensure our methodology remains rigorous and focused on where the pharma can make the most meaningful difference.

Access to medicine is more than a healthcare issue, it also questions how capital is used. Find out more in this episode of Health Equity podcast, where I speak with Rogier Snijdewind (PGGM) on how investors can drive real progress in access to medicines.

Speaking on a #G20 panel on addressing access to non communicable disease products and how to practical approaches to solve the health equity gaps and engage the pharmaceutical industry to deliver on affordable access. I shared independent insights from @accesstomedicinefoundation.org

In our Health Equity #ThroughHerLens I discuss with Dr Cardoso, Advanced Breast Cancer Alliance, the inequities in access to cancer care across geographies, income levels & gender. shorturl.at/jIkeS We highlight practical solutions that you can act on now. A must watch for all at #ASCO25

I’m honoured and grateful to see the work of the @accesstomedicinefoundation.org reflected in India Today. It’s a reminder of how far we’ve come, and how much more remains to be done to ensure equitable access to medicine, especially for women and underserved communities.

The 2025 MPP Prioritisation Report is out — spotlighting key medicines and health technologies for expanded global access! 🌍 🔗 Read the full report: medicinespatentpool.org/progress-ach... @unitaid.bsky.social @accesstomedicinefoundation.org @jayiyer.bsky.social

Great to see investors speaking up on the critical importance of safeguarding public health. These calls are timely and necessary as decisions made today will have lasting implications for equitable access to healthcare globally. Looking forward to seeing more investors join this important effort.

Really excited to share the first episode of this podcast series with a dear friend, Dr Joseph Saba, CEO of Axios International. We discussed the progress in HIV treatment access, the impact of funding aid cuts, and what it means for patients and the pharma industry.

Access to life-saving #NCD treatments shouldn't depend on where you live or what you can afford, but this is still the reality. With #UNGA HLM on NCDs ahead, it’s time to turn commitments into action. Our latest briefing outlines how policymakers can drive real impact.

Five years after COVID-19 reshaped global health, we now have the first global estimates of medical oxygen gaps and a plan to close them. The #GlobalOxygenAlliance welcomes the Lancet Global Health Commission report and its recommendations. Now, action is key. Read more: bitly.cx/3RIDN

U.S. aid cuts expose a deeper crisis: Africa’s reliance on imported meds is failing patients. Clinics rationing, treatments in limbo-this must be a turning point. Regional pharma can thrive with scale, investment & policy support. I explain why: bitly.cx/C9CW #GlobalHealth #HealthEquity @devex.com

Our team is at #EPAConf in Amsterdam today, engaging with key stakeholders on #healthcare access & #pharma accountability. Our CEO, @jayiyer.bsky.social, will deliver a keynote speech sharing insights on global #HealthEquity from the 2024 #AccesstoMedicine Index #ATMI24. Learn more➡️ bit.ly/4isqENQ

In an op-ed for @devex.com, our CEO, @jayiyer.bsky.social, highlights how recent US aid cuts & rising #healthcare nationalism are forcing Africa to rethink its reliance on external support, underscoring the urgent need for more made-in-Africa medicine. Read more➡️ bit.ly/3XsKRe0 #AccesstoMedicine

Earlier this week, we were told some of our programs were terminated in error. But we cannot restart our programming until we receive payment for the work that has already been done, which to-date exceeds $5m. We are calling on leaders to release funding so we can get back to work.

Ahead of #InternationalWomensDay, I’m proud to launch "Health Equity Through Her Lens". Women’s health is still sidelined. We know the barriers & solutions, yet #SRHR remains underfunded. We’re bringing together women leaders to push for real change. Read more here: bitly.cx/zH3H

We need to protect the progress made in global health. When funding shrinks and partnerships weaken, lives are at stake. Supply chains break, treatments stall, and decades of gains unravel. Industry and global health must step up now before all momentum is lost. www.linkedin.com/pulse/backbo...

Oxygen is life, yet >50% of the world's population still lack access to medical oxygen. A new Lancet Oxygen Global Health Commission report shows the scale of this crisis: 400M people need oxygen yearly, yet many go without. $6.8B/year could close the gap www.thelancet.com/journals/lan... 1/2

When floods, droughts, wildfires force millions fr their homes, they lose access to basic healthcare. By 2050, 1.2bil people could face this reality. In my op-ed I urge the #pharma industry to invest in supply chains & R&D in climate-sensitive diseases. bit.ly/4hdVMAb @projectsyndicate.bsky.social

Well said by @nickkristof.bsky.social on the unacceptable, unnecessary attack on existing Programmes for children. As an organization tracking progress in #access2meds globally the actions of the past days haunted us and also put decades of progress into jeopardy. @atmfoundation.bsky.social

I spoke to ESG Investor on the real impact of the U.S. pulling back on global health. This isn’t just policy - it’s a threat to lives. Pharma must step up, and investors must hold them accountable. Inaction isn’t an option, lives are on the line. accesstomedicinefoundation.org/in-the-media...

Elizabeth cared about her children and for all children living with HIV. But she didn’t stop at just caring. She fought every day of her life to ensure children with HIV had access to the care and treatment they needed to thrive. Today, we carry on her legacy of action.

Newly published research from Team EGPAF shows the lack of an NTD safety signal with dolutegravir conception. Researchers conducted a massive surveillance study in Eswatini, covering three-quarters of the facility deliveries in the country. pedaids.org/resource/bir...

“The whole story is lining up,” Toni Choueiri told me. @statnews.com www.statnews.com/2025/02/05/p...

What happens when a rare disease drug seems to work, but the health care system doesn’t? www.statnews.com/pharmalot/20... via @statnews.com

ESG Investor's Emmy Hawker spoke with the Foundation’s CEO, @jayiyer.bsky.social, about the financial & social risks of the US President’s decision to limit access to affordable, life-saving medicines & #healthcare. Read more➡️ bit.ly/3Q1cmr7 #AccesstoMedicine #HealthEquity #ESG #investing

Behind every cancer diagnosis is a unique human story—stories of resilience, grief, hope, and healing. People-centred care means seeing the whole person and meeting their unique needs with compassion and empathy. #WorldCancerDay

Out of 66 R&D projects for HIV and TB, only 11 focus on children -just 17%. That’s not enough. If we don’t speak up and act - we are complicit in leaving them behind. The solutions exist. Now we need the commitment to deliver. #GlobalHealth #AccessToMedicine #PaediatricHealth #HIV #TB

"Science should not have a political litmus test," Randy Schekman told @mmolteni.bsky.social at @statnews.com www.statnews.com/2025/02/03/t...

At the Vatican today discussing solutions to today’s needlessly exacerbated crisis with top leaders driving #hiv prevention & access programs globally. A city of hope, a powerful gathering. A man with a pen won’t stop our efforts. If you have means to help and invest in solutions pls get in touch.

In the early 2000s, RFK Jr was doing great work as an environmental lawyer taking on industrial hog farms, and we talked about going to NC together to document the problems. Then he started crazy talk about vaccines. My column on the threat he poses: www.nytimes.com/2025/02/01/o...

Great article on how much devastation is now taking place, because of irresponsible behavior from trump. Bravo those who speak up for the injustice & strive to save the countless lives affected and lost by this. We can change this if we act now.

Last year, we launched #ATMI24, showcasing an overall stagnation in #pharma companies’ efforts to improve access to essential healthcare products across #LMICs. While some modest progress has been made, the potential for improving access is still far from realised. Read more➡️ bit.ly/3NUREIk

When floods, droughts, wildfires force millions fr their homes, they lose access to basic healthcare. By 2050, 1.2bil people could face this reality. In my op-ed I urge the #pharma industry to invest in supply chains & R&D in climate-sensitive diseases. bit.ly/4hdVMAb @projectsyndicate.bsky.social

Imagine having access to pandemic data & cures for your child one day, and the next - nothing. No solidarity, no data-sharing, just bigger risks. Funny how Trump once said, 'America first,' but his policies seem more like 'America last' when it comes to protecting its people.

I’ve always used data to motivate the most unmovable folks to do more. #pharmawhisperer We have made big strides in preventing deaths globally. How can one person sign a death sentence for children needing access to #hiv treatment & prevention? @8illgates.bsky.social @billclinton.bsky.social

Last week I shared my thoughts with Bloomberg on Trump's executive order to withdraw U.S. support from WHO. Today, I write an open letter to President Donald Trump on why global collaboration is essential to safeguard not just American healthcare, but healthcare for all.